Plain-English translation of NCT04908709 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a special type of MRI scan called spectroscopic MRI (sMRI) can help doctors better plan and deliver radiation therapy for children with high-grade brain gliomas. The study has two main parts: first, doctors will collect baseline MRI information from patients before they receive standard radiation therapy to see if it predicts where tumors might come back; second, doctors will test whether this special MRI scan can safely be used to define the exact area that needs radiation treatment, potentially reducing radiation to healthy brain tissue.
Children with high-grade brain gliomas need radiation therapy, but doctors currently use standard MRI to plan treatment, which may not show the most active parts of the tumor. This trial exists to see whether a more detailed MRI technique can better identify tumor activity and help doctors design more precise, safer radiation plans that protect healthy brain tissue.
You likely qualify if…
You likely don't qualify if…
You will have special MRI scans before you start radiation therapy and then at several time points afterward (around 1 month, 4 months, and 7 months after treatment ends), as well as if doctors suspect the tumor has returned. Each MRI scan takes less than an hour, and you will continue to receive your standard radiation therapy as planned. Doctors will also track your health and quality of life during and after treatment to understand how this new imaging approach affects your overall care.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States